Provepharm Sas   Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: Marseilles France (1998)

Organization Overview

First Clinical Trial
2018
NCT03395223
First Marketed Drug
2016
methylene blue (proveblue)
First NDA Approval
2016
methylene blue (proveblue)
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Prove pharm | Provepharm Life Solutions | Provepharm SAS | PROVEPHARM SAS